Amneal Pharmaceuticals, Inc. (AMRX)
12.21
-0.04
(-0.33%)
USD |
NASDAQ |
Dec 12, 16:00
12.20
-0.01
(-0.08%)
After-Hours: 20:00
Amneal Pharmaceuticals Cash from Investing (Quarterly): -22.46M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AbbVie, Inc. | -3.264B |
| Johnson & Johnson | -542.00M |
| Amgen, Inc. | -414.00M |
| United Therapeutics Corp. | 140.90M |
| Xeris Biopharma Holdings, Inc. | -0.071M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 118.45M |
| Cash from Financing (Quarterly) | 59.44M |
| Free Cash Flow | 236.43M |
| Free Cash Flow Per Share (Quarterly) | 0.2956 |
| Free Cash Flow to Equity (Quarterly) | -7.845M |
| Free Cash Flow to Firm (Quarterly) | -122.08M |
| Free Cash Flow Yield | 6.05% |